Presentation is loading. Please wait.

Presentation is loading. Please wait.

Page 1 Increasing rates of earlier antiretroviral treatment associated with elevated levels of optimal virologic response among HIV-positive illicit drug.

Published byRose Stafford Modified over 8 years ago

Similar presentations

Presentation on theme: "Page 1 Increasing rates of earlier antiretroviral treatment associated with elevated levels of optimal virologic response among HIV-positive illicit drug."— Presentation transcript:

1 Page 1 Increasing rates of earlier antiretroviral treatment associated with elevated levels of optimal virologic response among HIV-positive illicit drug users during a Treatment-as-Prevention-based initiative in a Canadian setting M-J MILLOY, T KERR, R HOGG, S GUILLEMI, JSG MONTANER, E WOOD British Columbia Centre for Excellence in HIV/AIDS 8th International AIDS Society Conference on HIV pathogenesis, Treatment & Prevention Vancouver, 20 July 2015

2 Page 2 I have no conflicts of interest to declare.

3 Page 3 BACKGROUND TasP-based efforts seek to start PLWHA on HAART earlier in the disease course People who use illicit drugs (PWUD): sub- optimal access and adherence to HAART TasP-based efforts to scale-up HAART among PWUD have not been evaluated Will starting at higher CD4 (i.e., asymptomatic disease) degrade response to treatment?

4 Page 4 OBJECTIVES 1.Characterize temporal trends in CD4 at HAART initiation among PWUD during community-wide TasP 2.Test effect of initiating at higher CD4 on rates of virologic response in first year of treatment

5 Page 5 METHODS AIDS Care Cohort to evaluate Exposure to Survival Services (ACCESS) –Ongoing (2005-) observational prospective cohort –Recruited from community settings –Confidentially linked to comprehensive HIV TX records (ART, CD4, VL) Local setting: –Universal no-cost health care including ART –2005: Immediate HAART initiation

6 Page 6 RESULTS Between December 1, 2005 to June 1, 2013: –816 PWUD recruited –355 (44%): first HAART dispensation during period Among 355 participants: –130 (37%) non-male; 200 (56%) Caucasian –CD4: 200 cells/mL at initiation

7 Page 7

8 Page 8

9 Page 9

10 Page 10

11 Page 11 CONCLUSIONS 1.Participants initiating HAART earlier –130 cells/mL (2005) to 330 c/mL (2013); peak 380 c/mL (2011) 2.Earlier initiation associated with better virologic response –Adjusted Hazards Ratio: 1.14 per 100 c/mL increase 3.Findings support continued scale-up of HAART among PWUD as part of 90-90-90 efforts

12 Page 12 Acknowledgements Study participants for contributions to the research Current and past researchers and staff ACCESS supported by United States National Institutes of Health (R01-DA021525) M-JSM supported in part by US NIH (R01-DA021525) EW supported by a Tier 1 Canada Research Chair in Inner-City Medicine JSGM supported by grants paid to his institution by the British Columbia Ministry of Health and by the US National Institutes of Health (R01DA036307). He has also received limited unrestricted funding, paid to his institution, from Abbvie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, and ViiV Healthcare

Download ppt "Page 1 Increasing rates of earlier antiretroviral treatment associated with elevated levels of optimal virologic response among HIV-positive illicit drug."

Similar presentations

Assessment of the immediate HIV-related impact of the anti-gay law in Nigeria S. Schwartz, I. Orazulike, R. Nowak, S. Kennedy, S. Ketende, K. Ugoh, B.

Assessment of the immediate HIV-related impact of the anti-gay law in Nigeria S. Schwartz, I. Orazulike, R. Nowak, S. Kennedy, S. Ketende, K. Ugoh, B.
Page 1 Peer-delivered HIV testing and counseling among people who inject drugs in Bangkok, Thailand Lianping Ti 1 Kanna Hayashi 1,2 Karyn Kaplan 3 Paisan.

Page 1 Peer-delivered HIV testing and counseling among people who inject drugs in Bangkok, Thailand Lianping Ti 1 Kanna Hayashi 1,2 Karyn Kaplan 3 Paisan.
Slide 1 of 42 IAS–USA Treatment as Prevention: Evaluating the Impact of HAART Expansion The British Columbia (BC) Experience AU EDITED FINAL: 03-18-13.

Slide 1 of 42 IAS–USA Treatment as Prevention: Evaluating the Impact of HAART Expansion The British Columbia (BC) Experience AU EDITED FINAL:
Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.

Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.
High Rates of Tuberculosis in Patients Accessing HAART in Rural South Africa – Implications for HIV and TB Treatment Programs Kogieleum Naidoo on behalf.

High Rates of Tuberculosis in Patients Accessing HAART in Rural South Africa – Implications for HIV and TB Treatment Programs Kogieleum Naidoo on behalf.
PMTCT FAILURE: THE ROLE OF MATERNAL AND FACILITY –RELATED FACTORS ICASA Presentation 8 th to 12 th Dec 2013 Onono Maricianah 1, Elizabeth A. Bukusi 1,

PMTCT FAILURE: THE ROLE OF MATERNAL AND FACILITY –RELATED FACTORS ICASA Presentation 8 th to 12 th Dec 2013 Onono Maricianah 1, Elizabeth A. Bukusi 1,
Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,

Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,
Www.ias2013.org Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Abstract: WEABO205. HIV infection was associated with an increased risk of hip fracture,

Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Abstract: WEABO205. HIV infection was associated with an increased risk of hip fracture,
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.

Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Www.aids2014.org Operational challenge: Linkages from prevention of mother-to-child transmission services to care and treatment services in Zambia S. Okawa,

Operational challenge: Linkages from prevention of mother-to-child transmission services to care and treatment services in Zambia S. Okawa,
Introduction DCDOH supports HIV test and treat activities - increased number of HIV tests performed, emphasis on earlier linkage to care. Limited data.

Introduction DCDOH supports HIV test and treat activities - increased number of HIV tests performed, emphasis on earlier linkage to care. Limited data.
The effects of OAT and HAART on the cause-specific risk of mortality among HIV positive people who inject drugs Bohdan Nosyk, PhD Associate Professor,

The effects of OAT and HAART on the cause-specific risk of mortality among HIV positive people who inject drugs Bohdan Nosyk, PhD Associate Professor,
Page 1 HIV Treatment-as-Prevention (TasP) for people who use illicit drugs and implications for HCV TasP: The North American experience M-J MILLOY Research.

Page 1 HIV Treatment-as-Prevention (TasP) for people who use illicit drugs and implications for HCV TasP: The North American experience M-J MILLOY Research.
Prevention with Positives; Using Multiple Strategies to Involve Persons Living with HIV in Prevention. TASO Uganda. Emmanuel Odeke,

Prevention with Positives; Using Multiple Strategies to Involve Persons Living with HIV in Prevention. TASO Uganda. Emmanuel Odeke,
Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.

Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.
Patient Empowerment Impacts Medication Adherence among HIV-Positive Patients in the Veteran’s Health Administration Tan Pham 1,2,3, Kristin Mattocks 1,2,

Patient Empowerment Impacts Medication Adherence among HIV-Positive Patients in the Veteran’s Health Administration Tan Pham 1,2,3, Kristin Mattocks 1,2,
Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey.

Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey.
Baseline Antiretroviral Resistance Testing among HIV-Positive Injection Drug Users in a Canadian Setting Nadia Fairbairn 1 M-J Milloy 1 Thomas Kerr 1,

Baseline Antiretroviral Resistance Testing among HIV-Positive Injection Drug Users in a Canadian Setting Nadia Fairbairn 1 M-J Milloy 1 Thomas Kerr 1,
Increased clinical events in HIV-infected patients who achieve full virologic suppression but fail to attain a CD4 count ≥ 200 cells/mm 3 after one year.

Increased clinical events in HIV-infected patients who achieve full virologic suppression but fail to attain a CD4 count ≥ 200 cells/mm 3 after one year.
1 Dose-response relationship between incarceration and non- adherence to HAART among injection drug users in a Canadian setting M-J Milloy 1,2, T Kerr.

1 Dose-response relationship between incarceration and non- adherence to HAART among injection drug users in a Canadian setting M-J Milloy 1,2, T Kerr.

Similar presentations

Ads by Google